Molecular Structure image

Pipeline

Opioid Overdose

Product Candidate/Regulatory PathwayPreclinicalPhase IPhase IIPhase IIINDAFDA Approval
NARCAN® Nasal Spray*Approved
OPNT003 Nalmefene Nasal Spray
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval

Partnerships*

Alcohol Use Disorder

Product Candidate/Regulatory PathwayPreclinicalPhase IPhase IIPhase IIINDAFDA Approval
OPNT002 Opioid Antagonist Nasal Spray
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval

Acute Cannabinoid Overdose

Product Candidate/Regulatory PathwayPreclinicalPhase IPhase IIPhase IIINDAFDA Approval
OPNT004 Drinabant (CB-1 Antagonist)
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval

Partnerships

Opioid Use Disorder

Product Candidate/Regulatory PathwayPreclinicalPhase IPhase IIPhase IIINDAFDA Approval
OPNT005 Heroin Vaccine: hapten + liposome adjuvant*
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval
OPNT006 Opioid Antagonist Implant
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval

Partnerships*

WRNMMC